Carbone, C. et al. 2013. TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance. JOP. Journal of the Pancreas. 14, 5S (Sep. 2013), 562. DOI:https://doi.org/10.6092/1590-8577/1866.